Project Objective: Other (only use for Training, Conference, or other non research/development grants)
UC Santa Barbara Bio Sciences II
We propose a CIRM Special Program (Research Element X), supporting basic and discovery research that will fund renovation of space to provide for the establishment of a new Center for Stem Cell Biology and Engineering. CIRM funding will allow us to expand our growing basic research on human embryonic stem cells (hESC) by creating a […]
UCLA CIRM Institute
OVERVIEW: The CIRM Facility will support ~19K+ ASF of laboratory and vivarium not subject to federal human embryonic stem cell (hESC) restrictions including: 1) Research labs, 2) Core facilities, and 3) Career Development space. The Facility is adjacent to biology, chemistry, engineering, medicine, and clinical/translational programs, including our Stem Cell Center (SCC), FDA compliant GMP […]
UC Davis CIRM Institute
The proposed new CIRM Stem Cell Institute, to be located at a major public university, will be the center of scientific and clinical activity to bring stem cell therapies to patients in the State of California. This institution has a long-standing reputation for being highly collaborative, sharing resources and infrastructure, and for providing outreach and […]
UC Irvine CIRM Institute
The Stem Cell Research Program will build upon a long history of achievement in regeneration and developmental biology. Program scientists have made key contributions to developing stem cells, understanding how and why cells are lost in aging, understanding how tissues regenerate, and developing methods to make high purity cells from human embryonic stem (hES) cells […]
Stanford SIM1 Building
This application will describe the depth and breadth of our Stem Cell Programs in the “CIRM Institute” category. We are requesting funds to help with the construction costs for our Institute of Stem Cell Biology and Regenerative Medicine, a free-standing new building dedicated to our Stem Cell Programs. Currently, our stem cell program and our […]
UC Berkeley CIRM Center of Excellence
The Stem Cell Center is a cornerstone program of campus biomedical research that capitalizes on our strengths in basic and preclinical research, as well as collaborations with neighboring research institutions, to support high impact investigations with several major emphases: (1) stem cell self-renewal, (2) hematopoietic differentiation, (3) neural differentiation and neurodegeneration, (4) cardiovascular and skeletal […]
Sanford Consortium for Regenerative Medicine
The San Diego Consortium for Regenerative Medicine (“SDCRM”) is a nonprofit organization formed to marshal the intellectual resources of four world-leaders in life sciences research, including the Burnham Institute for Medical Research, the Salk Institute for Biological Studies, The Scripps Research Institute and the University of California, San Diego. In addition to the collective strength […]
CIRM Center of Excellence at Buck Institute for Age Research
Facility The Buck Institute for Age Research proposes to develop a CIRM Major Facility to investigate the role of stem cells in aging and in the pathogenesis, diagnosis and treatment of age-related disease. A new building devoted to human embryonic stem cell (hESC) research will be constructed adjacent to space earmarked for our CIRM Shared […]
Medical School Loan Repayment Program
Because the regenerative capacity of adult heart is limited, any substantial cell loss as a result of a heart attack is mostly irreversible and may lead to progressive heart failure. Human pluripotent stem cells can be differentiated to heart cells, but their properties when transplanted into an injured heart remain unresolved. We propose to perform […]
Medical School Loan Repayment Program
Many fetuses with congenital blood stem cell disorders such as sickle cell disease or thalassemia are prenatally diagnosed early enough in pregnancy to be treated with stem cell transplantation. The main benefit to treating these diseases before birth is that the immature fetal immune system may accept transplanted cells without needing to use immunosuppressant drugs […]